• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Bracket names Jeff Kinell CEO

Bracket names Jeff Kinell CEO

October 6, 2014
CenterWatch Staff

Bracket, a clinical trial specialty services provider, has announced the addition of Jeffrey W. Kinell as CEO and new member of its board of directors.

Kinell brings more than 30 years of experience to Bracket, primarily in leadership positions in growth-oriented health services and pharmaceutical outsourcing firms. Most recently, he was CEO of CRI Lifetree, a mid-sized specialized research organization focused in early phase clinical development. During his five-year tenure, Kinell oversaw the firm’s transformation into a scientifically driven organization offering highly specialized capabilities across multiple therapeutic areas.

“Jeff intimately understands the pharma/biotech specialty clinical space and the unique demands of clinical trials in multiple therapeutic areas and across multiple study phases,” said David G. Daniel, M.D., Bracket senior vice president and chief medical director. “This, combined with his broad experience across science, technology and operations, makes him the perfect fit for Bracket, especially as we continue to innovate and grow as an independent, privately held company.”

Jim Primerano, Bracket senior vice president and general manager for the eClinical group, said, “Jeff’s experience and leadership will be invaluable to our existing team, and Bracket and our clients are going to benefit greatly from his years of providing dynamic solutions to the biopharmaceutical market. He has a true commitment to innovative products and a unique perspective from actually dealing with the practical challenges of implementing technology solutions in a clinical environment. He sees the obvious benefits of adopting technology solutions in clinical trials to create efficiencies and improve quality.”

Bracket partners with sponsors and CROs to achieve greater certainty and accurate outcomes in their clinical trials by providing a combination of scientific, technological and operational support, from phase I to post approval. Bracket is a member of the Electronic Patient-Reported Outcome (ePRO) Consortium, a program of the Critical Path Institute (C-Path), which collaborates in a non-competitive, neutral environment to develop guidelines and advance the quality of electronic data collection methods for PROs. Bracket operates in the U.S., U.K., Continental Europe and Japan.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing